These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 36187418)
1. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity. Louden EM Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418 [TBL] [Abstract][Full Text] [Related]
3. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility. Eccleston-Turner M; Upton H Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737 [TBL] [Abstract][Full Text] [Related]
4. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap. Forman L; Jackson C; Fajber K Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686 [TBL] [Abstract][Full Text] [Related]
5. COVAX and equitable access to COVID-19 vaccines. Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037 [TBL] [Abstract][Full Text] [Related]
6. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa. Hassan MA; Aliyu S Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499 [TBL] [Abstract][Full Text] [Related]
7. The Race for Global Equitable Access to COVID-19 Vaccines. Md Khairi LNH; Fahrni ML; Lazzarino AI Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194 [TBL] [Abstract][Full Text] [Related]
8. Risky business: COVAX and the financialization of global vaccine equity. Stein F Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439 [TBL] [Abstract][Full Text] [Related]
9. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future. Pilkington V; Keestra SM; Hill A Front Public Health; 2022; 10():821117. PubMed ID: 35321196 [TBL] [Abstract][Full Text] [Related]
10. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic. Altindis E Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957 [No Abstract] [Full Text] [Related]
11. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness. Amin T; Kesselheim AS Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939 [TBL] [Abstract][Full Text] [Related]
12. Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries. Fox A J Health Polit Policy Law; 2024 Feb; 49(1):43-72. PubMed ID: 37522368 [TBL] [Abstract][Full Text] [Related]
13. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together. Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616 [TBL] [Abstract][Full Text] [Related]
14. COVAX, vaccine donations and the politics of global vaccine inequity. de Bengy Puyvallée A; Storeng KT Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116 [TBL] [Abstract][Full Text] [Related]
15. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap. Borges LC; Zeferino de Menezes H; Crosbie E Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975 [TBL] [Abstract][Full Text] [Related]
16. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study. Grenfell RFQ; Oyeyemi OT Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309 [TBL] [Abstract][Full Text] [Related]
17. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines. Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347 [No Abstract] [Full Text] [Related]
18. COVID-19 Vaccines: Ensuring Social Justice and Health Equity among Refugees in Africa. Manirambona E; Hague O; Trajano LF; Killen A; Wilkins L; Nkeshimana M; Lucero-Prisno Iii DE Ann Glob Health; 2021; 87(1):106. PubMed ID: 34786354 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes? Geiger S; McMahon A J Med Ethics; 2023 Aug; 49(8):583-590. PubMed ID: 34848492 [TBL] [Abstract][Full Text] [Related]